RxSight Corp - RXST Short-Term Debt to Capital
RxSight, Inc. (RXST) delegates electronics manufacturing and logistics to external partners to support clinics. The business relies on a single laser-guided lens platform, making revenue dependent on the adoption of the technology. A price visualization featuring the 0.01 metric, which assists in the basic asset valuation, is available below. High barriers to entry are ensured by patents and strict FDA control, protecting the niche from competitors.
Analytical breakdowns for RxSight, Inc.
RxSight, Inc. (RXST) is rapidly scaling the deployment of its innovative lenses, requiring significant working capital to support peak demand. This trend is reflected in the sensitivity of liabilities maturing within one year relative to the volume of equity. This metric measures the company's reliance on short-term borrowing, thereby determining liquidity risk. Analyzing the ratio of short-term debt to equity allows for an assessment of the balance between aggressive growth and financial stability.